A 3-D view of the mesh: microtubules (green tubes) of the mitotic spindle are held together by a yellow network, the mesh.
Credit: Warwick Medical School
University of Warwick researchers have
discovered a cell structure which could help scientists understand why
some cancers develop.
For the first time a structure called 'the mesh' has been identified
which helps to hold together cells. This discovery, which has been
published in the online journal eLife, changes our understanding of the cell's internal scaffolding.
This also has implications for researchers' understanding of cancer
cells as the mesh is partly made of a protein which is found to change
in certain cancers, such as those of the breast and bladder.
The finding was made by a team led by Dr Stephen Royle, associate
professor and senior Cancer Research UK Fellow at the division of
biomedical cell biology at Warwick Medical School. Dr Royle said: "As a
cell biologist you dream of finding a new structure in cells but it's so
unlikely. Scientists have been looking at cells since the 17th Century
and so to find something that no-one has seen before is amazing."
Researchers at the University's Warwick Medical School made the
discovery by accident while looking at gaps between microtubules which
are part of the cells' 'internal skeleton'. In dividing cells, these
gaps are incredibly small at just 25 nanometres wide -- 3,000 times
thinner than a human hair.
One of Dr Royle's PhD students was examining structures called
mitotic spindles in dividing cells using a technique called tomography
which is like a hospital CAT scan but on a much smaller scale. This
meant that they could see the structure which they later named the mesh.
Mitotic spindles are the cell's way of making sure that when they
divide each new cell has a complete genome. Mitotic spindles are made of
microtubules and the mesh holds the microtubules together, providing
support. While "inter-microtubule bridges" in the mitotic spindle had
been seen before, the researchers were the first to view the mesh.
The study received funding and support from Cancer Research UK and North West Cancer Research.
Dr Royle said: "We had been looking in 2D and this gave the
impression that 'bridges' linked microtubules together. This had been
known since the 1970s. All of a sudden, tilting the fibre in 3D showed
us that the bridges were not single struts at all but a web-like
structure linking all the microtubules together."
The discovery impacts on the research into cancerous cells. A cell
needs to share chromosomes accurately when it divides otherwise the two
new cells can end up with the wrong number of chromosomes. This is
called aneuploidy and this has been linked to a range of tumours in
different body organs.
The mitotic spindle is responsible for sharing the chromosomes and
the researchers at the University believe that the mesh is needed to
give structural support. Too little support from the mesh and the
spindle will be too weak to work properly, however too much support will
result in it being unable to correct mistakes. It was found that one of
the proteins that make up the mesh, TACC3, is over-produced in certain
cancers. When this situation was mimicked in the lab, the mesh and
microtubules were altered and cells had trouble sharing chromosomes
during division.
Dr Emma Smith, senior science communications officer at Cancer
Research UK, said: "Problems in cell division are common in cancer --
cells frequently end up with the wrong number of chromosomes. This early
research provides the first glimpse of a structure that helps share out
a cell's chromosomes correctly when it divides, and it might be a
crucial insight into why this process becomes faulty in cancer and
whether drugs could be developed to stop it from happening."
North West Cancer Research (NWCR) has funded the research as part of a
collaborative project between the University of Warwick and the
University of Liverpool, where part of the research is being carried
out.
Anne Jackson, CEO at NWCR, said: "Dr Royle and Professor Ian Prior at
the University of Liverpool have made significant inroads into our
understanding of the way in which cancer cells behave, which could
potentially better inform future cancer therapies.
"As a charity we fund only the highest standard of research, as evidenced by Dr Royle's work.
"All our funded projects undergo a thorough peer review process,
before they are considered by our scientific committee. Our specially
selected scientific committee includes some of the UK's leading
professors, award-winning scientists and pioneering professionals."
Story Source:
The above post is reprinted from
materials provided by
University of Warwick.
Note: Materials may be edited for content and length.